Phase III study of intensive weekly chemotherapy with recombinant human granulocyte colony-stimulating factor versus standard chemotherapy in extensive-disease small-cell lung cancer : The Japan Clinical Oncology Group
収録刊行物
-
- J Clin Oncol
-
J Clin Oncol 16 2126-2132, 1998